Optimizing Adherence to Antiretroviral Therapy

  • Author: Nancy Reynolds, PhD, RN, C-NP, FAAN (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 3/21/18 (What's New)

Summary

  • Psychiatric and substance abuse disorders, particularly untreated depression, are associated with reduced adherence to ART [Malta 2010; Pence 2009; Whetten 2008; Azar 2010; Farley 2010; Kacanek 2015]
  • Comorbid illnesses may be associated with lower adherence because of the complexity of managing multiple treatment regimens and adverse effects from drug interactions
  • Baseline medical evaluation should consider previously diagnosed and undiagnosed comorbid conditions and the number and frequency of coadministered medications as factors that may influence adherence

Action required

Keywords: Adherence, Cardiovascular Disease, Drug-Drug Interactions, Initial Antiretroviral Therapy, Psychiatric Disorders, Tuberculosis, Viral Hepatitis Coinfection

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.